R.H. Bluestein & Co’s Labcorp LH Stock Holding History

R.H. Bluestein & Co’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$266K	Hold	1,513	–	–	0.02%	260
2022 Q2	$305K	Hold	1,513	–	–	0.02%	242
2022 Q1	$343K	Hold	1,513	–	–	0.01%	262
2021 Q4	$408K	Hold	1,513	–	–	0.01%	244
2021 Q3	$366K	Sell	1,513 -233	-13%	-$58.7K	0.01%	274
2021 Q2	$414K	Sell	1,746 -1,164	-40%	-$265K	0.02%	257
2021 Q1	$638K	Buy	2,910 +1,164	+67%	+$234K	0.03%	166
2020 Q4	$305K	Hold	1,746	–	–	0.01%	280
2020 Q3	$282K	Hold	1,746	–	–	0.01%	257
2020 Q2	$249K	Buy	+1,746	New	+$242K	0.01%	272
2015 Q2	–	Sell	-4,656	Closed	-$504K	–	341
2015 Q1	$504K	Buy	+4,656	New	+$479K	0.03%	161
2014 Q2	–	Sell	-3,492	Closed	-$295K	–	373
2014 Q1	$295K	Buy	+3,492	New	+$278K	0.02%	280

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

R.H. Bluestein & Co's LH Position: Q3 2022 in Review

R.H. Bluestein & Co held its Labcorp (LH) position steady in Q3 2022 at 1,513 shares worth $266K. The position accounts for 0.02% of the portfolio, ranked #260.

R.H. Bluestein & Co first reported a position in LH in Q1 2014 and has held it in 12 quarters since. The position peaked at $638K in Q1 2021. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

R.H. Bluestein & Co held 1,513 shares of Labcorp worth $266K as of Q3 2022.
R.H. Bluestein & Co left its Labcorp share count unchanged in Q3 2022.
Labcorp made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #260 holding.
R.H. Bluestein & Co first reported a position in Labcorp in Q1 2014 and has held it in 12 quarters since.
R.H. Bluestein & Co's Labcorp position peaked at $638K in Q1 2021.
936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.